Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Johnson and Johnson

Known as: Johnson & Johnson 
health product manufacturer
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
IntroductionTheoretical risks of biologic agents remain under study.ObjectiveThe aim of this study was to integrate 1-year safety… Expand
2014
2014
STARR with CONTOUR® TRANSTAR™ device for obstructed defecation syndrome: one-year real-world outcomes of the European TRANSTAR registry
PurposeStapled transanal rectal resection (STARR) in patients with obstructive defecation syndrome (ODS) is limited by the… Expand
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
2013
2013
First novel anti-tuberculosis drug in 40 years
  • R. Osborne
  • Nature Biotechnology
  • 2013
    • Corpus ID: 20639439
89 opment organization, established in 2000 to boost research into TB drugs. Sirturo, unlike other antibiotics that attack the… Expand
  • table 1
Highly Cited
2012
Highly Cited
2012
Sting of Alzheimer's failures offset by upcoming prevention trials
Three prevention trials in asymptomatic Alzheimer's disease patients will attempt to validate the amyloid hypothesis, evaluate… Expand
  • table 1
  • figure 1
  • table 2
Review
2010
Review
2010
How Informatics Can Potentiate Precompetitive Open‐Source Collaboration to Jump‐Start Drug Discovery and Development
Much enthusiasm and energy are being directed toward open‐source software approaches, precompetitive data sharing, and external… Expand
2010
2010
Phase 2 Study of 2 Modalities of Pomalidomide (CC4047) Plus Low-Dose Dexamethasone as Therapy for Relapsed Multiple Myeloma. IFM 2009-02
Abstract 859 Method: This study was addressed to patients with MM who were symptomatic and progressive following at least two… Expand
Highly Cited
2009
Highly Cited
2009
Numerical and Clinical Accuracy of a Continuous Glucose Monitoring System during Intravenous Insulin Therapy in the Surgical and Burn Intensive Care Units
Background: Intensive insulin therapy (IIT) for glycemic control in critically ill patients has been shown to be beneficial… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 6
Highly Cited
2008
Highly Cited
2008
The Bacteria Fight Back
In their ongoing war against antibiotics, the bacteria seem to be winning, and the drug pipeline is verging on empty. 
2008
2008
Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
BackgroundIn clinical practice, physicians often need to change the antipsychotic medications they give to patients because of an… Expand
  • table 1
  • table 2
  • table 3
  • table 4
2005
2005
An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening.
In this paper we describe an initial reproducibility study of 12 proprietary compounds followed by the assessment of 51 marketed… Expand
  • table I
  • table II
  • figure 1
  • table III
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE